Myungmoon Pharmaceutical "Terminated M2N as the Preferred Negotiation Partner for Major Shareholder Stake Sale"
[Asia Economy Reporter Ji Yeon-jin] Myungmoon Pharmaceutical announced on the 12th that it has terminated M2N as the preferred negotiation partner regarding the sale of shares by the largest shareholder.
Hot Picks Today
Trump: "Ceasefire Extension Unlikely... Ceasefi...
- "Six Months After 'Mom's Touch Troublesome Woman' Incident... Franchise Says, 'S...
- "Is '2 Million Hynix' Really Possible? Brokers Raise Target Price for SK hynix [...
- Tim Cook Steps Down as Apple CEO After 15 Years, Will Become Chairman of the Boa...
- Female Game Caster Makes Bold Move After Criticism Over "Short Skirt" on Broadca...
The company explained, "In the future, if other sale discussions proceed or specific details are confirmed regarding the sale of shares by the largest shareholder, we will disclose them later."
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["They Said It Was 'Delicious' Milk... Is the 'List of Fake Milk Products in Korea' for Real? [Matjal X-File]"](https://cwcontent.asiae.co.kr/asiaresize/307/2023072413274517286_1690172865.jpg)
